Kloppenborg P W, Casparie A F, Benraad T J, Majoor C L
Acta Med Scand. 1975 Jan-Feb;197(1-2):99-108. doi: 10.1111/j.0954-6820.1975.tb04885.x.
Heparin and the heparinoid Ro 1-8307 inhibited the secretory rate of aldosterone in physiological or pathological aldosteronism to the level found in normal subjects on liberal sodium intake. In addition, these compounds inhibited corticosterone biosynthesis, although less markedly than that of aldosterone. Indications of interference with cortisol production have not been found. During drug treatment angiotensin, in doses of 5-10 ng/kg b.wt./min, did not stimulate aldosterone secretion. ACTH responsiveness of the adrenals--indicated by the fractional increases of both aldosterone and corticosterone secretory rates--remained unchanged. In two studies heparin had no consistent effect on plasma renin activity.
肝素及类肝素Ro 1-8307可将生理或病理性醛固酮增多症患者的醛固酮分泌率抑制至正常受试者高钠摄入时的水平。此外,这些化合物可抑制皮质酮的生物合成,尽管其抑制作用不如对醛固酮的抑制作用明显。尚未发现其干扰皮质醇生成的迹象。在药物治疗期间,剂量为5-10 ng/kg体重/分钟的血管紧张素不会刺激醛固酮分泌。醛固酮和皮质酮分泌率的分数增加表明,肾上腺对促肾上腺皮质激素(ACTH)的反应性保持不变。在两项研究中,肝素对血浆肾素活性没有一致的影响。